PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 33: Articles 16001-16500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Oral contraceptive use and risk of stroke [letter]
  2. Oral contraceptive use in woman's life cycle in developing countries.
  3. The oral contraceptive user.
  4. Oral contraceptives and arterial hypertension. [Contraceptivos orais e hipertensao arterial.]
  5. Oral contraceptives and blood pressure: a study on interrelationship.
  6. Oral contraceptives and breast cancer: what has 20 years of research shown?
  7. Oral contraceptives and cervical cancer [letter]
  8. Oral contraceptives and cervical cancer. In reply [letter]
  9. Oral contraceptives and cervical carcinoma in situ in Chile.
  10. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
  11. Oral contraceptives and fat patterning in young adult women.
  12. Oral contraceptives and focal nodular hyperplasia of the liver.
  13. Oral contraceptives and gallstones [letter]
  14. Oral contraceptives and hypertension.
  15. Oral contraceptives and intrahepatic biliary cystadenoma having an increased level of estrogen receptor.
  16. Oral contraceptives and lipid metabolism.
  17. Oral contraceptives and lipid metabolism: interim analysis of the PROCAM trial.
  18. Oral contraceptives and prodromal symptoms in fatal pulmonary embolism in young women. [P-piller og prodromalsymptomer ved fatal lungeemboli hos unge kvinner.]
  19. Oral contraceptives and the hemostatic system.
  20. Oral contraceptives and venous thromboembolic disease: the effect of the oestrogen dose.
  21. Oral contraceptives.
  22. Oral contraceptives. Risk factors for cardiovascular disease. Chance association or causal relation? [Orale Kontrazeptiva -- Risikofaktor fur Herz-Kreislauf-Ereignisse -- zufallige Assoziation oder kausale Beziehung?]
  23. Oral contraceptives. Risks and advantages. [Orale Kontrazeptiva. Risiken und Vorzuge.]
  24. Oral contraceptives: effects on glucose and lipid metabolism in insulin-dependent diabetic women and women with previous gestational diabetes. A clinical and biochemical assessment.
  25. Oral contraceptives: hormonal dose and effects on carbohydrate metabolism.
  26. Oral steroidal contraception: scientific basis and recent development.
  27. Ordinance No. 88-19 authorizing the practice of contraception, 7 April 1988.
  28. Origin of zona pellucida antigens and its relevance to the development of contraceptive vaccine.
  29. Ovarian function after the menarche and hormonal contraception.
  30. Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives.
  31. The ovulation method and the politics of contraception.
  32. Palmar eczema: a pathogenetic role for acetylsalicylic acid, contraceptives and smoking?
  33. Pamphlets about oral contraceptives. [Information packet]
  34. Pamphlets about voluntary surgical contraception. [Information packet]
  35. Parents' behavioral norms as predictors of adolescent sexual activity and contraceptive use.
  36. Parity and the contraceptive sponge [letter]
  37. Parity and the contraceptive sponge, letter] Reply.
  38. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
  39. Patients at STD clinics may benefit if facilities also offer birth control.
  40. Patients, problems and family planning clinics.
  41. Patterns of sexual behaviour among sexually experienced women attending family planning clinics in England, Scotland and Wales.
  42. Paucity of family planning.
  43. Paying for family planning in China.
  44. Peptides and proteins for male contraception: problems and prospects. [Peptides et proteines pour une contraception chez l'homme: problemes et perspectives.]
  45. Performance indicators for family planning services [letter]
  46. Performance report: choice of family planning services among poor women. (RO 1 - FP00015)
  47. Peru: OR project links AIDS prevention and family planning.
  48. Pharmaceutical effect of contraceptive pills on the skin.
  49. Phase I clinical trial of a World Health Organisation birth control vaccine.
  50. The phenomenon of single contraceptive villages: an application of the minisurvey data collection tool.
  51. Philippines. Knowledge and attitudes of grassroots family planning workers about contraceptive methods.
  52. Physiological coagulation inhibitors (protein S, protein C and antithrombin III) in severe preeclamptic states and in users of oral contraceptives.
  53. Planned Parenthood Federation of America v. Bowen, 25 February 1988.
  54. Planned Parenthood Federation of America, Inc. v. Agency for International Development, 29 January 1988.
  55. Planned Parenthood of Southeastern Pennsylvania v. Casey, 13 June 1988.
  56. Plasma glucose and insulin levels in women using a levonorgestrel-containing triphasic oral contraceptive for three months.
  57. Plasma rifampicin levels during oral contraception.
  58. Policies and family planning programmes in Africa: evaluation and prospects.
  59. Politics of the birth control programme in India.
  60. Polymorphous light eruption and oral contraceptives.
  61. Population and family planning data: what do policymakers really want to know?
  62. Population and family planning in Korea.
  63. Population and family planning research, Bangladesh. An annotated bibliography, fourth volume.
  64. Population and family planning research, Bangladesh: an annotated bibliography, Vol. 4.
  65. Population control and family planning in India.
  66. Population growth in Zambia and the need for family planning. Brief manual.
  67. Population growth, development work, and family planning (the church's experience in the third world) [Bevolkerungswachstum, Entwicklungsarbeit und Familienplanung (kirchliche Erfahrung in der Dritten Welt)]
  68. Population policy and family planning in the third world. [Bevolkerungspolitik und Familienplanung in der Dritten Welt.]
  69. Post-coital contraception -- a two year evaluation of a service.
  70. Post-coital contraception.
  71. Post-coital contraceptive use by adolescents: analysis of contraceptive behaviour before and after.
  72. Postcoital contraception using a desogestrel-ethinyl estradiol combination. [Contraccezione post-coitale con una associazione desogestrel-etinilestradiolo.]
  73. Postcoital contraception.
  74. Postcoital contraception: some characteristics of women who use this method.
  75. Postmarketing evaluations help determine contraceptive safety, efficacy.
  76. Postmolar contraception.
  77. Postpartum contraception and sex life during the puerperium. [Contraception et vie sexuelle dans les suites de couches.]
  78. Postpartum contraception.
  79. The potential demand for family planning: a new measure of unmet need and estimates for five Latin American countries.
  80. The potential demand for family planning: new data on unmet needs and estimates for five Latin American countries.
  81. Potential for bias in case-control studies of oral contraceptives and breast cancer.
  82. Practice and methods of contraception among Saudi women in Riyadh.
  83. Prazosin, an adrenergic blocking agent inadequate as male contraceptive pill.
  84. Pre-systemic metabolism of the oral contraceptive steroid desogestrel.
  85. Predicting Mexican-American family planning intentions: an application and test of a social psychological model.
  86. Predicting pregnancy and contraceptive usage among college women.
  87. Prediction factors of contraceptive behaviour of single girls aged 15 to 19.
  88. Predominant sexually transmitted diseases among different age and ethnic groups of indigent sexually active adolescents attending a family planning clinic.
  89. Pregnancy outcome associated with natural family planning (NFP): scientific basis and experimental design for an international cohort study.
  90. The premarital family planning education should be started during puberty.
  91. Premenstrual syndrome and oral contraceptives of different character.
  92. The present status of family planning.
  93. Presentation C: Contraception -- a lifelong perspective.
  94. Pretesting of contraceptive advertisements using focus group research.
  95. The prevalence of Neisseria gonorrhoea and Chlamydia trachomatis in intra-uterine contraceptive acceptors in Kenya.
  96. Preventing a crisis: AIDS and family planning work.
  97. Preventing a crisis: family planning associations and AIDS.
  98. Primary health care and family planning in Nepal: some points for discussion.
  99. Principles and practice in designing and evaluating effective IEC materials for family planning and AIDS awareness campaigns in Thailand. Thailand country report.
  100. Principles of the use of oral contraceptive preparations. [Printsipi na prilozhenie na oralnite kontratseptivni preparati.]
  101. The private organized sector. Approach to family planning in Kenya.
  102. The private sector and family planning in developing countries.
  103. PROALMA: Breastfeeding and Family Planning Project update.
  104. The problems of oral contraceptives in dope control of anabolic steroids.
  105. The process of finding contraceptive options.
  106. A profile of acceptors of terminal methods of family planning in a rural community.
  107. Progestagen-dependent effect on some plasma proteins during oral contraception.
  108. Progesterone antagonists: useful for contraception?
  109. Progestogens for contraception.
  110. Prognostic value of modifications in the blind spot in women taking contraceptives (letter) [Valeur pronostique de la modification de la tache aveugle chez les femmes prenant des contraceptifs.]
  111. Program impacts on contraceptive distribution and method mix in the Indonesian Family Planning Program: causal modeling with pooled cross-sectional and time series data from East Java.
  112. Program performance II: the assessment of Asian family planning programs, 1960-1985.
  113. Programmatic factors in contraceptive use-effectiveness: lessons learned from operations research.
  114. Progress of contraceptive methods. OC and IUD.
  115. Projected fertility and contraceptive use.
  116. Promoting family planning among industrial workers.
  117. Proper attitude to natural family planning.
  118. Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months.
  119. Prospects for family planning in 1991 in Tunisia. [Les perspectives de la planification familiale en 1991 en Tunisie.]
  120. Provisional Regulations on Minority Peoples' Birth Control, 1988.
  121. Psychological factors related to contraceptive use by unmarried college women.
  122. Psychosocial factors in contraceptive efficacy.
  123. Public attitudes toward teenage pregnancy, sex education and birth control.
  124. Public opinion and the adoption of family planning in a village ward in West Java, 1970-1973.
  125. A qualitative study on the reasons why the rural people in Nan province use contraceptive.
  126. Racial differences in contraceptive choice: complexity and implications.
  127. Recent developments in barrier methods of contraception.
  128. Recent levels and trends in the use of anti-contraceptives. [Niveles y tendencias recientes del uso de anticonceptivos.]
  129. Recent trends in contraceptive use and current practice of contraception in China: in-depth fertility survey (phase I)
  130. Recent trends in human contraception.
  131. Receptor study on contraceptive steroids.
  132. Recovery of the intrauterine contraceptive device from the sigmoid colon. Three case reports.
  133. Redefining family planning: feminist perspectives on service delivery.
  134. Reduced anaerobic glycolysis in oral contraceptive users.
  135. Reducing late abortions: access to NHS services in early pregnancy. Proceedings of a conference organised by the Birth Control Trust on 16 September 1987 at the Royal Society of Medicine, London.
  136. Reevaluating women's contraceptive needs.
  137. Reevaluation of the contraceptive pill in continuous use. [Rivalutazione di pillola contraccettiva ad assunzione continua.]
  138. Reflections on the future of family planning.
  139. Relation of control, sexual conduct, contraception and pregnancy in adolescents. [Relacion de control, conducta sexual, anticonceptiva y embarazo en adolescentes.]
  140. The relationship between MCH service development and contraceptive use: evidence from Matlab, Bangladesh.
  141. Relationship between the sex behavior of couples, men, and lack of information on family planning. [Relacion entre comportamiento sexual de la pareja, el hombre y la falta de informacion sobre planificacion familiar.]
  142. Relationships between contraceptive education and adolescent male contraceptive behavior.
  143. The relative reliability of oral contraceptives; findings of an epidemiological study.
  144. Religion and conservative husbands balk at family planning.
  145. Religious affiliation and contraceptive usage: changing American patterns, 1955-82.
  146. Report from instructors' education in NFP = Natural Family Planning. [Rapport fran handledarutbildning i N.F.P = Naturlig Familjeplanering.]
  147. Report of Meeting on Breast Cancer and Oral Contraceptives, Geneva, 27-28 June 1988.
  148. Report of the study on the organizational issues in community participation in national family planning programmes: a comparative analysis of five countries in the ESCAP region.
  149. Report on a national workshop for broadcast media and family planning/health personnel in the development of family planning/health radio programmes, held at the Expatriate Training Centre, Institute of Adult Education, Morogoro, Tanzania, 12-16 January, 1988.
  150. Report on the Family Planning in the Private Sector Conference, Sheraton Hotel, Lagos, Nigeria, September 29-30, 1988.
  151. Reproductive behavior and family planning.
  152. Reproductive decision-making and the use of modern contraceptives in rural Peru.
  153. Reproductive health and reproductive freedom: maternal health care and family planning in the Swedish health system.
  154. Reproductive outcome and contraception. [Exito reproductivo y anticoncepcion.]
  155. Resolution containing the agreement with INSALUD in the matter of family planning, 21 November 1988.
  156. Resource needs for population and family planning activities in less developed countries.
  157. A response to Dr. Ravenel's editorial [on American teens and birth control] [letter]
  158. Results and advantages of integrating family planning into maternal and child health care services. [Effets et advantages de l'integration du bien-etre familial dans les services de sante maternelle et infantile.]
  159. Results and advantages of integrating family planning into maternal and child health care services. [Effets et avantages de l'integration du bien-etre familial dans les services de sante maternelle et infantile.]
  160. Results and advantages of integrating family planning with maternal and child health services. [Effets et avantages de l'integration du bien-etre familial dans les services de protection maternelle et infantile.]
  161. Results of a clinical study with low-dose oral contraceptives. Investigation with triphasic and monophasic preparations containing levonorgestrel and ethinylestradiol.
  162. Results of a qualitative study of an operations research project in family planning in N'Djamena. [Resultats de l'etude qualitative du projet de recherche operationnelle sur le bien-etre a N'Djamena.]
  163. Results of a quantitative study in family planning in N'Djamena. [Resultats de l'etude quantitative sur le bien-etre familial a N'Djamena.]
  164. Retailer's contraceptive training manual for Liberia.
  165. Retrieval of a lost intrauterine contraceptive device under ultrasound control.
  166. Retrieval of intrauterine contraceptive devices with missing tails, using Lamicel.
  167. A retrospective epidemiological investigation of the contraceptive efficacy of IUDS.
  168. A review of infection control for family planning clinics.
  169. A review of population projections and the family planning program in Indonesia 1980-2000 (by the new component method): part II. 2nd edition.
  170. Review of the Family Planning Training Worldwide PAC II Project: 1984 - 1987.
  171. Risk taking as a predictor of adolescent sexual activity and use of contraception.
  172. Risks and benefits of oral contraceptive use in women over 35.
  173. Risks and mechanisms of cardiovascular events in users of oral contraceptives.
  174. The role of family planning availability in motivating fertility regulation, Egypt, 1984: a multilevel analysis.
  175. The role of family planning in promoting health.
  176. The role of family planning in women's development. [Role du bien-etre familial sur le developpement de la femme.]
  177. The role of family planning units in the prevention of female tumors. [Le donne, i consultori e la prevenzione dei tumori femminili.]
  178. Role of health delivery services in acceptance of family planning in Gujarat, Phase-II.
  179. The role of health information systems in the management of family planning in Chad. [Le role du systeme d'information sanitaire dans la gestion des activites de bien-etre familial au Tchad.]
  180. The role of individuals' socioeconomic characteristics and the government family planning program in China's fertility decline.
  181. The role of men in family planning. [Le role de l'homme dans le bien-etre familial.]
  182. The role of non-governmental organizations in AIDS prevention: parallels to African family planning activity.
  183. Role of nurses in promoting contraceptive devices.
  184. The role of public sector agencies in contraceptive research and development.
  185. The role of sexual self-concept in the use of contraceptives.
  186. Role of temperature in regulation of spermatogenesis and the use of heating as a method for contraception.
  187. The role of the media in developing family planning services in Chad. [Le role des media dans le developpement des services du bien-etre familial au Tchad.]
  188. The role of the private sector in family planning. [Le role du secteur prive dans le bien-etre familial.]
  189. The role of the private sector in family planning. [Le role du secteur prive dans le bien-etre familial.]
  190. The role of women's organizations in primary health care with special reference to maternal and child health including family planning. Report of an interregional meeting, Jakarta, 23-26 November 1987.
  191. Safe and voluntary surgical contraception: guidelines for service programs.
  192. Salivary and plasma free testosterone and androstenedione levels in women using oral contraceptives containing desogestrel or levonorgestrel.
  193. Saving lives through family planning, a Latin American and Caribbean perspective.
  194. Saving lives with family planning. The case in Latin America and the Caribbean. [Salvando vidas con planificacion familiar. El caso en America Latina y el Caribe.]
  195. Scope of work. USAID / Cairo buy-in to the Enterprise Program. HIO Family Planning Services Project.
  196. Searching for a postpartum contraceptive.
  197. Selection of contraception for the individual.
  198. Self-care agency and limitations with respect to contraceptive behavior of Mexican American women.
  199. Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive.
  200. Serum lipid profile in women using levonorgestrel contraceptive implant, Norplant-2.
  201. Serving contraceptive clients in developing countries. Performance of projects funded by Family Planning International Assistance in 1986.
  202. The seventh national workshop on the interruption of pregnancy and contraception. [Septiemes journees nationales d'etudes sur l'interruption de grossesse et la contraception.]
  203. Seventh semi-annual report, 15 September 1987 -14 March 1988, INOPAL project. Operations Research to Improve Family Planning and Maternal-Child Health Service Delivery Systems in Latin America and the Caribbean (DPE-3030-C-00-4074-00)
  204. Sex selection: the ultimate in family planning.
  205. Sexual and reproductive life events in relation to duration of oral contraceptive use.
  206. Sexual behaviour, contraceptive practice and knowledge of AIDS of Oxford University students.
  207. Sexual experience and contraceptive use among young adults in Mexico City.
  208. Sexual, contraceptive, and pregnancy choices: counseling adolescents.
  209. Sexually transmitted diseases and contraceptive choice.
  210. Sexually transmitted diseases and sexual behavior in urban adolescent females attending a family planning clinic.
  211. Sexually transmitted diseases: implications for family planning programs. Discussion summary.
  212. Shannxi provincial family planning work.
  213. Signs of fertility: the personal science of natural birth control.
  214. Sinusoid dilatations and intake of oral contraceptives. Report of one case with review of the literature. [Dilatations sinusoidales et prise de contraceptifs oraux. A propos d'un cas avec revue de la litterature.]
  215. Sinusoidal dilatation of the liver in patients on oral contraceptives. Electron microscopical study of 14 cases.
  216. Sister chromatid exchanges in the lymphocytes of control women, pregnant women, and women taking oral contraceptives: effects of cell culture temperature.
  217. The situation of population development, population policy and family planning measures of China.
  218. A small library in family planning.
  219. The social context of sexual and contraceptive behaviour of adolescents in the Netherlands.
  220. Social differences in fertility in light of family planning surveys. [A termekenyseoj tarsadelmi kulonbsegei a csaladtervezesi vizsgalatok tukreben.]
  221. Social marketing of oral rehydration therapy and contraceptives in Egypt.
  222. Some characteristics of rural acceptors of family planning measures.
  223. Some comments on the status of family planning in Colombia. [Algunos comentarios sobre la situacion de la planificacion familiar en Colombia."]
  224. Some considerations on family planning and contraception worldwide and in Rwanda. [Quelques considerations sur la planification familiale et la contraception dans le monde et au Rwanda.]
  225. Some demographic and family planning characteristics at the governorate level, Egypt, 1984.
  226. Some medico legal problems associated with contraception.
  227. Speech opening the first conference on family planning October 15-21, 1988. [Discours d'overture de la premiere conference sur le bien-etre familial (du 15 au 21 Octobre 88)]
  228. Sperm protein holds key to contraceptive vaccine.
  229. Sri Lanka. Knowledge and attitudes of grassroots family health workers about contraceptive methods.
  230. Statutory Prohibition on Use of Appropriated Funds in Programs Where Abortion is a Method of Family Planning; Standard of Compliance for Family Planning Services Projects, 29 January 1988.
  231. Statutory prohibition on use of appropriated funds in programs where abortion is a method of family planning; standard of compliance for family planning services projects. Part 59 of Title 42 (Public Health) of the United States Code of Federal Regulations. Dated 28 January 1988.
  232. STD, sterility, contraception -- or influence on sexuality. [MST, sterilite, contraception, etc. ou le sexe sous influence.]
  233. Steroid contraceptive use and pregnancy outcome.

     

  234. Steroid implants for long-term contraception.
  235. Stimulating the commercial sector to invest in family planning through cost-benefit projections.
  236. The strategies, experiences and future challenges of the information component in the Indonesian Family Planning Programme.
  237. Strategy of providing quality services through family planning programmes.
  238. Strength of fertility motivation and contraceptive use in Nepal.
  239. Strengthening the management of family planning at the basic level to further control the growth of population.
  240. Studies on prolactin stimulation with metoclopramide in women on oral contraceptives. [Untersuchungen zur Prolaktin-Stimulierbarkeit mit Hilfe des Metoclopramid-Tests bei Frauen unter oralen Kontrazeptiva.]
  241. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
  242. A study of fertility and contraception in Mpraeso (eastern region of Ghana)
  243. Study of grassroot workers for development of effective strategy in the delivery of health and contraceptive care services in rural India: a case study.
  244. Study of knowledge, practice and attitudes regarding contraceptives. [Estudio de conocimiento, habitos de uso y actitudes hacia los anticonceptivos.]
  245. A study of relationship between background characteristics, media exposure and acceptance of family planning in rural Maharashtra.
  246. Study on the method of manual inspection of the external uterine orifice included in the new rhythm method of family planning.
  247. A study on the release rate of contraceptive vaginal ring (CVR) containing megestrol acetate in vitro.
  248. Study summaries: Family Planning Operations Research/Asia Project.
  249. Summary of nineteenth national survey on family planning.
  250. Summary of the Third National Workshop of the Integrated Family Planning, Nutrition and Parasite Control Project.
  251. Surgical contraception in Korea.
  252. Surgical hysteroscopy in preventing the occurrence of Asherman's syndrome following the removal of intrauterine contraceptive devices. [Operatsionnaia gisteroskopiia v profilaktike vozniknoveniia sindroma Ashermana pri udalenii vnutrimatochnykh kontratseptivov.]
  253. Survey finds low contraceptive use among sexually active youth.
  254. A survey of family planning in the Philippines.
  255. Survey uncovers surprising phenomenon: single contraceptive villages. Thailand.
  256. Systemic lupus erythematosus: contraception and pregnancy. [Lupus erythemateux dissemine: contraception et grossesse.]
  257. Technology and health: the readability of commercial versus generic contraceptive instructions.
  258. Teen Council urges improved contraceptive accessibility.
  259. Teens conduct contraceptive accessibility survey.
  260. Teens' survey of stores in the District of Columbia on accessibility of family planning methods.
  261. Television and family planning practice in urban Nigeria, II: the NTA / Ibadan experience.
  262. Temporal relation of ovulation to salivary and vaginal electrical resistance patterns: implications for natural family planning.
  263. Temporary methods of contraception. [Les methodes temporaires.]
  264. Third national survey on prevalence and use of contraceptives and first in demography and health. [Tercera Encuesta Nacional de Prevalencia del Uso de Anticonceptivos y Primera de Demografia y Salud, 1986.]
  265. Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene. [Trente ans apres la contraception orale, analyse clinique et biologique d'une nouvelle association estroprogestative triphasique au gestodene.]
  266. Three Honduran surveys reveal signs of declining fertility, rising contraceptive use during the 1980s.
  267. A three-year study of the Copper-7 Minigravigard intrauterine contraceptive device in nulliparous women.
  268. To improve family planning work by studying new situations and solving new problems.
  269. To integrate family planning into the building up of mental civilization by offering comprehensive services.
  270. Tolerance of the triphasic oral contraceptive Trinovum. [Vertraglichkeit und Akzeptanz der norethisteronhaltigen Dreistufenpille Trinovum.]
  271. Trace elements during 2 years' oral contraception with low-estrogen preparations.
  272. Traditional family planning methods in sub-Saharan Africa. [Les methodes tradionnelles de planification familiale en Afrique sub-Saharienne.]
  273. Traditional methods of contraception in Chad. [Methodes contraceptives traditionnelles au Tchad.]
  274. Traditional methods of contraception.
  275. Trainer's guide to family planning counseling.
  276. Training of family planning personnel.
  277. Transdermal contraceptive delivery system: development, scaleup manufacturing and evaluations.
  278. Treatment of acne with an antiandrogen containing contraceptive (Diane 35) [Az akne kezelese antiandrogent tartalmazo fogamzasgatloval (Diane 35)]
  279. Trends in contraception and contraceptive research.
  280. Trends in contraceptive use among university women, 1974-1983: a decade of change.
  281. Trends in hormonal contraception.
  282. Trends of contraceptive research.
  283. Tumors of the liver and oral contraceptives. Diagnostic problems, therapeutic indications. [Tumeurs du foie et contraceptifs oraux. Problemes diagnostiques, indications therapeutiques.]
  284. Tunisia: FP program grows, but contraceptive use lags in some areas.
  285. The Tunisian experience in family planning: recorded results. [L'experience Tunisienne en matiere de planning familial: resultats enregistres.]
  286. Twenty-eight-day oral contraceptives: physician and user attitudes.
  287. A twin study of the psychiatric side effects of oral contraceptives.
  288. Ulamas play very important role in NTB family planning programme.
  289. Ultrasound-guided intrauterine removal of intrauterine contraceptive devices in pregnancy.
  290. UMATI: national family planning trainer.
  291. A uniform national medical record and data collection for family planning associations.
  292. Unintended pregnancy, contraceptive practice and family planning services in developed countries.
  293. Unmet needs in family planning.
  294. Up-regulatory effect of triphasic oral contraceptive on platelet 3H-imipramine binding sites.
  295. Update on postcoital hormonal contraception. Part 1. [Attualita in tema di contraccezione post coitale di tipo ormonale. (Parte prima)]
  296. Use of estrogens in post-coital contraception. Our case material of 243 cases. [Uso degli estrogeni nella contraccezione post-coitale. Nostra casistica di 243 casi.]
  297. The use of folk media for community motivation. A process and experience in the promotion of family planning and health.
  298. The use of Gn-RH analogues in Marcumar-treated patients for contraception and prophylaxis of potentially fatal ovulatory hemorrhage. [Einsatz von Gn-RH-Analoga bei markumarisierten Patientinnen zur Antikonzeption und Prophylaxe von lebensbedrohlichen Ovulationsblutungen.]
  299. The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection.
  300. The use of medroxyprogesterone acetate (Depo-Provera) in Sheffield Health Authority family planning clinics in 1986.
  301. Use of oral contraceptives in women of older reproductive age.
  302. The use of parity progression models in evaluating family planning programmes.
  303. Use of the Omega intrauterine contraceptive device in reconstructive operations on the uterine body. [Zastosowanie wewnatrzmacicznych wkladek antykoncepcyjnych "Omega" przy operacjach rekonstrukcyjnych trzonu macicy.]
  304. Users' attitudes about Norplant contraceptive subdermal implants and changes that occur with use of the method. Answers to open-ended questions, Dominican Republic. Second of a two-part report submitted to the Population Council by CEMICAMP in fulfillment of Grant No. I86.50A.
  305. Using family planning to decrease infant mortality: the case of low birthweight infants.
  306. Vaginal contraceptives: effective protection from sexually transmitted diseases for women?
  307. Vaginal pills: systemic contraception induced by vaginal administration of contraceptive pills.
  308. Variations in family planning program implementation in four counties in rural China.
  309. Views and practices of the Philippino family planning clinic "drop-outs".
  310. Villages as contexts for contraceptive behavior in rural Egypt.
  311. In vitro inactivation of HIV-1 by contraceptive sponge containing nonoxynol-9 [letter]
  312. Voluntarism and voluntary surgical contraception.
  313. Voluntary surgical contraception in Brazil.
  314. Walking on a fairly tight rope: policy formation for AIDS in the family planning world.
  315. What accounts for the increase in contraceptive use in Peninsular Malaysia, 1956-75? -- development vs. family planning program effort.
  316. What killed contraceptive research and development?
  317. What the populations of Maradi and Zinder think about family planning. Report of focus group interviews carried out in Maradi and Zinder in February 1988. [Ce que les populations de Maradi - Zinder pensent du planning-familial. (Rapport d'interviews de groupes realises a Maradi - Zinder en Fevrier 1988)]
  318. Whatever happened to the contraceptive revolution?
  319. WHO Special Programme in Human Reproduction and Contraceptive Needs of Developing Countries.
  320. Why doesn't family planning reduce the infant mortality rate more? An interestingly misleading demographic discovery.
  321. Why you should know about natural family planning.
  322. Women and AIDS: the challenge to family planning.
  323. Women at risk: the need for family planning services, state and county estimates, 1987.
  324. Women held most receptive to advice on prenatal care, infant care, family planning during pregnancy.
  325. Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill.
  326. Women, fertility, and family planning in Africa.
  327. Worker-client contacts and contraceptive adoption: experience from the MCH-FP extension project.
  328. Workers' participation improves contraceptive practices.
  329. Workshop on Market-Based Distribution of Health and Family Planning Services, May 18-22, 1987, Ibadan, Nigeria, summary report.
  330. Workshop on the integration of AIDS related curricula into family planning training programs, Quality Hotel, Arlington, Virginia, May 10-11, 1988. Documents.
  331. Workshop on the integration of AIDS-related curricula into family planning training programs, May 10-11, 1988, Quality Hotel, Arlington, Virginia.
  332. World trends in contraceptive use, by method, and their relationship to fertility.
  333. Clinical experience with ethynodiol diacetate 0.5 mg daily as an oral contraceptive.
  334. Coagulation effects of oral contraception.
  335. A comparison of a new graduated estrogen formulation with three constant-dosed oral contraceptives.
  336. Sex hormone abnormalities in systemic lupus erythematosus. Effect of contraceptives. [Nemi hormon abnormalitasok systemas lupus erythematosusban. Fogamzasgatlok hatasa.]
  337. Sexual activity, contraceptive use, and other risk factors for symptomatic and asymptomatic bacteriuria: a case-control study.
  338. Sexual behavior, contraceptive practice, and reproductive health among Liberian adolescents.
  339. Access to health care and family planning in Swaziland: law and practice.
  340. Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.
  341. Oral contraceptives, cigarette smoking and other factors in relation to arthritis.
  342. Belgian trial of an oral contraceptive containing 0.150 mg desogestrel and 0.020 mg ethinylestradiol.
  343. Breast cancer risk in relation to type of estrogen contained in oral contraceptives.
  344. Can general practice provide adequate experience to teach family planning?
  345. Changes in plasma HDL-cholesterol in women using oral contraceptives in Kenya.
  346. Characteristics of contraceptive acceptors in Lusaka, Zambia.
  347. Clinical acceptability, use-patterns and use-effectiveness of the vaginal contraceptive sponge and neo sampoon tablets--an international multi-center randomized clinical trial.
  348. A clinical comparison in Finland of two oral contraceptives containing 0.150 mg desogestrel in combination with 0.020 mg or 0.030 mg ethinylestradiol.
  349. Contraception: an overview.
  350. Contraceptive and fertility behavior of family planning clinic dropouts: a Maryland study.
  351. Contraceptive failure in the United States: a critical review of the literature.
  352. Contraceptive prevalence and family planning program effort in Zimbabwe.
  353. The contraceptive sponge's protection against Chlamydia trachomatis and Neisseria gonorrhoeae.
  354. Contraceptive use and fertility in Honduras, 1981-84.
  355. Contraceptive use and fertility in Panama, 1984.
  356. Contraceptive uses, pelvic inflammatory disease, and fertility problems among American women.
  357. Contrasting diet and body mass among users and nonusers of oral contraceptives and exogenous estrogens: the Lipid Research Clinics Program Prevalence Study.
  358. The contribution of social science research to population policy and family planning program effectiveness.
  359. Development of a low-dose monthly injectable contraceptive system: II. Pharmacokinetic and pharmacodynamic studies.
  360. Effect of long-term oral contraceptive therapy before pregnancy on maternal and fetal zinc and copper status.
  361. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.
  362. The effect of oral contraceptives on hormone profiles of oligomenorrheic adolescent cycles.
  363. The effect of triphasic and biphasic oral contraceptive preparations on HDL-cholesterol and LDL-cholesterol in young women.
  364. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
  365. The effects of contraceptive hormones on the replication of Chlamydia trachomatis in human endometrial cells.
  366. Effects of seven low dose combined oral contraceptives on high density lipoprotein subfractions.
  367. Effects of the oral contraceptive combination 0.150 mg desogestrel + 0.020 mg ethinylestradiol on serum lipids including the HDL subfractions.
  368. Effects of the oral contraceptive combination 0.150 mg desogestrel +0.020 mg ethinylestradiol on serum lipids, SHBG, glycosylated proteins and plasma antithrombin III activity in healthy women.
  369. Effects of the oral contraceptive combination 0.150 mg desogestrel plus 0.020 mg ethinylestradiol on carbohydrate metabolism in healthy female volunteers.
  370. Effects of three low-dose oral contraceptive combinations on sex hormone binding globulin, corticosteroid binding globulin and antithrombin III activity in healthy women: two monophasic desogestrel combinations (containing 0.020 or 0.030 mg ethinylestradiol) and one triphasic levonorgestrel combination.
  371. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
  372. Endometrial histology during intermittent intranasal luteinizing hormone-releasing hormone (LH-RH) agonist sequentially combined with an oral progestogen as an antiovulatory contraceptive approach.
  373. Endometrial morphology after 6 months of continuous treatment with a new gonadotropin-releasing hormone superagonist for contraception.
  374. Family planning clinic services in U.S. counties, 1983.
  375. Family planning in Bangladesh, 1969-1983.
  376. Family planning in Botswana, Kenya and Zimbabwe.
  377. Family planning services and contraception in Shomolu, Lagos, Nigeria.
  378. Fertility and family planning in Papua New Guinea; a reply.
  379. First premarital contraceptive use: United States, 1960-82.
  380. German trial of an oral contraceptive containing 0.150 mg desogestrel plus 0.020 mg ethinylestradiol.
  381. Heterogeneous distribution of serum prolactin values in apparently healthy young women, and the effects of oral contraceptive medication.
  382. Hormonal contraception: benefits versus risks.
  383. Influence of oral contraceptives on blood pressure following pregnancy induced hypertension. [Der Einfluss hormoneller Kontrazeptiva auf den Blutdruck nach schwangerschaftsinduzierter Hypertonie.]
  384. Influence of Vitamin E administration on platelet functions in hormonal contraceptive users.
  385. The interaction between sex hormone binding globulin and levonorgestrel released from Norplant, an implantable contraceptive.
  386. Intra-uterine contraceptive devices (IUDs) in relation to uterine histology and microbiology.
  387. A low-dose triphasic oral contraceptive.
  388. LRH agonist buserelin as a post-partum contraceptive: lack of biological activity of buserelin in breast milk.
  389. Luteal contraception.
  390. Malignant hypertension in women of childbearing age and its relation to the contraceptive pill.
  391. Metabolic effects of oral contraceptives.
  392. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
  393. Metabolic investigations with Femodene - an oral contraceptive containing gestodene and ethinyloestradiol.
  394. Microdose intrauterine levonorgestrel for contraception.
  395. Natural family planning.

     

  396. A new delivery system for contraceptive steroids.
  397. A new low-dose estrogen oral contraceptive combination: effect on endocrine parameters and lipid status.
  398. New progestogens in oral contraceptives.
  399. Oral contraception and insulin sensitivity: in vivo assessment in normal women and women with previous gestational diabetes.
  400. Oral contraception with a triphasic combination of gestodene and ethinyl estradiol: results of a multicenter clinical study.
  401. Ovarian neoplasms, functional ovarian cysts, and oral contraceptives.
  402. Ovulation detection following removal of levonorgestrel subdermal contraceptive implants.
  403. Parity and the effectiveness of the Today contraceptive sponge.
  404. Partner involvement and contraceptive efficacy in premarital sexual relationships.
  405. Phasic approach to oral contraceptives.
  406. Pituitary response to LHRH in long-term users of injectable contraceptives.
  407. Planned Parenthood experience with Triphasil.
  408. Postcoital contraception with dienogest. [Postkoitale Kontrazeption mit Dienogest.]
  409. Postcoital contraception with dl-norgestrel/ethinyl estradiol combination: six years experience in a student medical clinic.
  410. Postcoital contraception with levonorgestrel during the peri-ovulatory phase of the menstrual cycle.
  411. Postcoital test abnormalities in relation to contraceptive use.
  412. Postplacental insertion of the spiked and the standard lippes loop in early postpartum contraception.
  413. Pregnancy after removal of Norplant implants contraceptive.
  414. Presence of ethynyl-estradiol (EE-2) in blood and endometrium after interrupting steroidal contraception for three months.
  415. Primary care--mothers and babies: a strategy in three parts for improving the uptake of new or established family planning services.
  416. The progesterone antagonist RU 486: a potential new contraceptive agent.
  417. The relationship of tubal infertility to barrier method and oral contraceptive use.
  418. The relative impact of smoking and oral contraceptive use on women in the United States.
  419. The role of contraceptive use in cervical cancer: the Maryland Cervical Cancer Case-Control Study.
  420. Serum lipids levels with fixed low dose and triphasic oral contraceptive pills.
  421. Sex education and family planning services for adolescents in foster care.
  422. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk. ICMR Task Force Study on Hormonal Contraception.
  423. Trends in fertility, family size preferences, and family planning practice: Taiwan, 1961-85.
  424. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
  425. Underreporting of contraceptive use in Bangladesh.
  426. Unplanned pregnancies, family planning problems and child maltreatment.
  427. Urinary melatonin, LH, oestradiol, progesterone excretion during the menstrual cycle or in women taking oral contraceptives.
  428. Use and misuse of oral contraceptives by adolescents attending a free-standing clinic.
  429. Venous thromboembolism in relation to oral contraceptive use.
  430. Hormonal contraception: new long-acting methods./Os anticoncepciones hormonais: novos metodos de acao prolongada./La contraception hormonale : nouvelles methodes a effet retard./La anticoncepcion hormonal: nuevos metodos de accion prolongada.
  431. Employment-based family planning programs./Programas de planejamento familiar com base no emprego./L'emploi et le planning familial./Integracion de los programas de planificacion familiar en el empleo.
  432. Clinical experience with a norgestrel releasing intrauterine contraceptive device. [Kliniske erfaringer med hormonspiral.]
  433. Clinical observations on LRH-A used for contraception by luteolysis in normal women--analysis of 88 cases.
  434. Clinical performance of a levonorgestrel-releasing intracervical contraceptive device during the first year of use.
  435. The clinical pharmacology of the oral contraceptive and drugs which alter its activity.
  436. Clinical trial of gossypol as a male contraceptive drug. Part I. Efficacy study.
  437. Clinical trial of gossypol as a male contraceptive drug. Part II. Hypokalemia study.
  438. Clinical, pharmacological and epidemiological studies on a levonorgestrel implant contraceptive.
  439. Clinician examination. Birth control in the schools.
  440. A clinician's experience with postcoital contraception at a university health service.
  441. Closing the link between health care and family planning.
  442. Coagulation tests and oral contraceptives. Evaluation of the thromboembolytic risks. [Esami dell'emostasi e contraccettivi orali. Valutazione del rischio tromboembolico.]
  443. Cognitive and affective determinants of males' contraceptive behavior: comparing scripts and goals to attitudes and sexual emotion as predictors of condom use.
  444. Cognitive development and adolescent contraception: integrating theory and practice.
  445. College men's knowledge of the fertile time of the menstrual cycle and contraceptives.
  446. Colposcopy in a family planning clinic: a future model?
  447. Combination oral contraceptive use and the risk of endometrial cancer.
  448. Combined contraceptives and cardiovascular risk. [Contraception estroprogestative et risque cardiovasculaire.]
  449. Combined estrogen-progestagen contraception in 1987 and its complications. [La contraception orale estroprogestative en 1987 et ses complications.]
  450. Communication in family planning: India's experience.
  451. Communications and family planning.
  452. Community action for family planning: a comparison of six project experiences.
  453. Community and individual acceptance: family planning services in the Sudan.
  454. Community communication networks and family planning behaviour. Regional report of the Pilot Study on the Role of Community Communication Networks in the Acceptance and Continuance of Family Planning Practice.
  455. Community marketing of contraceptives. [El mercadeo comunitario en anticonceptivos.]
  456. Community participation in family planning: case studies from Bangladesh.
  457. Community participation in family planning: some suggestions for organisation development and management change.
  458. Community-based contraceptive distribution: a Korean success story.
  459. Community-based distribution of contraceptives in Kenya.
  460. Comparative analysis of the effectiveness of the diaphragm and birth control pill during the first year of use among suburban adolescents.
  461. A comparative clinical study of the effects of three types of low-dose estrogen/progestogen oral contraceptives.
  462. A comparative study of the incidence of Gardnerella vaginalis in users of IUD and oral contraceptives. [Estudo comparativo da incidencia de Gardnerella vaginalis em usuarias de dispositivos intra-uterinos e anticoncepcionais orais.]
  463. Comparative study of the knowledge, opinions and practice of family planning among female industrial workers and housewives.
  464. Condom distribution by women in a municipal hospital family planning clinic.
  465. Condom sense: a condom distribution project in a municipal hospital family planning clinic.
  466. Sex education: prerequisite for family planning. [Education sexuelle: prealable necessaire a la planification familiale.]
  467. Sex, contraception and conceptions of sex.
  468. Sex, politics, and the bottom line: "selling" company-based family planning.
  469. Sex, sex guilt, and contraceptive use revisited: the 1980's.
  470. Sex, sex guilt, and contraceptive use revisited: the 1980s.
  471. Sexual activity, contraceptive use and pregnancy among Mexican-American and white non-Hispanic adolescent women.
  472. Sexual attitudes and contraception among females across five college samples.
  473. Sexual experience and contraceptive use among young adults in Guatemala City.
  474. Sexual experience and use of contraception among young adults in Latin America.
  475. Sexuality and contraception in adolescence. [Sexualitat und Kontrazeption in der Adoleszenz.]
  476. Sexuality and family planning: perspectives for the mentally ill and handicapped.
  477. Sexuality, reproduction and family planning. [Sexualidade, reproducao y planejamento familiar.]
  478. SHBG, testosterone, androstenedione, 17-OH-progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive.
  479. Side effects and compliance with low- and conventional-dose oral contraceptives among adolescents.
  480. Side effects of contraceptive methods in Thailand.
  481. Significant bacteremia associated with replacement of intrauterine contraceptive device.
  482. Simultaneous presence in utero of two intrauterine contraceptive devices inserted consecutively. [Ednovremenno nalichie in utero na dva posledovatelno postaveni vutrematochni kontratseptivni pesara.]
  483. Slowing the stork: better health for women through family planning.
  484. Smoking, oral contraceptives, and cardiovascular disease: an international perspective.
  485. Smoking, oral contraceptives, and other risk factors for atherosclerotic heart disease.
  486. The social and political environment, fertility, and family planning program effectiveness.
  487. A social psychologic model of female adolescents' compliance with contraceptives.
  488. The social psychology of contraception and prophylaxis: what we already know about using condoms.
  489. Socialist spiritual civilization enhances consciousness in family planning.
  490. Socio-cultural factors influencing family planning in Egypt and policy redirections.
  491. Socio-economic factors in family planning adoption.
  492. Socio-professional categories and contraceptive methods used by urban dwellers. Study involving 12, 036 women consulting gynecologists. [Categories socio-professionnelles et methode contraceptive en milieu urbain. Etude de 12 036 consultantes en cabinet gynecologique.]
  493. Sociocultural factors associated with contraceptive use in Puerto Rico.
  494. The sociodemographic determinants of contraceptive method choice in Sri Lanka: 1975-1982.
  495. Socioeconomic development, family planning, and fertility in China.
  496. Some aspects of family planning and population reproduction. [Einige Aspekte zur Familienplanung und Bevolkerungsreproduktion.]
  497. Some aspects of family planning programmes and fertility in selected ECA member states.
  498. Some characteristics and background data of users of so called "Methods of Natural Family Planning (NFP)"
  499. The 13th Asian Parasite Control / Family Planning Conference. "Towards Further Development of Family Health Education through Video". Proceedings.
  500. The 1985 intercensal survey of Indonesia: 6. Trends in contraceptive prevalence.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.